FdaApplication
NDA 209521
Identifiers
- fda_app_no: NDA209521
Properties
| Property | Value |
|---|---|
| applicant_name | ALMIRALL LLC |
| application_type | NDA |
| approval_date | 2018-10-01 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| SEYSARA | SARECYCLINE HYDROCHLORIDE | EQ 100MG BASE | TABLET;ORAL |
| SEYSARA | SARECYCLINE HYDROCHLORIDE | EQ 60MG BASE | TABLET;ORAL |
| SEYSARA | SARECYCLINE HYDROCHLORIDE | EQ 150MG BASE | TABLET;ORAL |
3 products